Related references
Note: Only part of the references are listed.Amalgamation of in-silico, in-vitro and in-vivo approach to establish glabridin as a potential CYP2E1 inhibitor
Shipra Bhatt et al.
XENOBIOTICA (2021)
Carbon Monoxide Inhibits Cytochrome P450 Enzymes CYP3A4/2C8 in Human Breast Cancer Cells, Increasing Sensitivity to Paclitaxel
Brian Kawahara et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Assessment of Metabolic Interaction between Repaglinide and Quercetin via Mixed Inhibition in the Liver: In Vitro and In Vivo
Ji-Min Kim et al.
PHARMACEUTICS (2021)
Assessing CYP2C8-Mediated Pharmaceutical Excipient-Drug Interaction Potential: A Case Study of Tween 80 and Cremophor EL-35
Chengming Wen et al.
PHARMACEUTICS (2021)
Myricetin: A comprehensive review on its biological potentials
Muhammad Imran et al.
FOOD SCIENCE & NUTRITION (2021)
Influence of MAMA decoction, an Herbal Antimalarial, on the Pharmacokinetics of Amodiaquine in Mice
Awodayo O. Adepiti et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2020)
Cytochrome 450 metabolites of arachidonic acid (20-HETE, 11,12-EET and 14,15-EET) promote pheochromocytoma cell growth and tumor associated angiogenesis
Cecilia Colombero et al.
BIOCHIMIE (2020)
A review on myricetin as a potential therapeutic candidate for cancer prevention
Nazia Afroze et al.
3 BIOTECH (2020)
A Multi-layered Variable Selection Strategy for QSAR Modeling of Butyrylcholinesterase Inhibitors
Vinay Kumar et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer's disease
Vinay Kumar et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2020)
Current Pharmacological Trends on Myricetin
Gudiya Gupta et al.
DRUG RESEARCH (2020)
Inhibitory Mechanisms of Myricetin on Human and Rat Liver Cytochrome P450 Enzymes
Dan Lou et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2019)
Trans-resveratrol, but not other natural stilbenes occurring in food, carries the risk of drug-food interaction via inhibition of cytochrome P450 enzymes or interaction with xenosensor receptors
Lucie Hyrsova et al.
TOXICOLOGY LETTERS (2019)
Characterization of human cytochrome P450 mediated bioactivation of amodiaquine and its major metabolite N-desethylamodiaquine
Yongjie Zhang et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Effect of piperine on CYP2E1 enzyme activity of chlorzoxazone in healthy volunteers
Satish Kumar Bedada et al.
XENOBIOTICA (2017)
In vitro inhibition of human CYP2E1 and CYP3A by quercetin and myricetin in hepatic microsomes is not gender dependent
Johanna Ostlund et al.
TOXICOLOGY (2017)
Effects of Angiotensin II Receptor Blockers on Metabolism of Arachidonic Acid via CYP2C8
Asuna Senda et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Flavonoids and phenolic acids from cranberry juice are bioavailable and bioactive in healthy older adults
Diane L. McKay et al.
FOOD CHEMISTRY (2015)
The Influence of Single-Dose and Short-Term Administration of Quercetin on the Pharmacokinetics of Midazolam in Humans
Mai Anh Nguyen et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Effect of Resveratrol on the Pharmacokinetics of Carbamazepine in Healthy Human Volunteers
Satish Kumar Bedada et al.
PHYTOTHERAPY RESEARCH (2015)
The Reliability of Estimating Ki Values for Direct, Reversible Inhibition of Cytochrome P450 Enzymes from Corresponding IC50 Values: A Retrospective Analysis of 343 Experiments
Lois J. Haupt et al.
DRUG METABOLISM AND DISPOSITION (2015)
Elevated 14,15-epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer
Xiaolong Wei et al.
BMC CANCER (2014)
Glucuronidation Converts Clopidogrel to a Strong Time-Dependent Inhibitor of CYP2C8: A Phase II Metabolite as a Perpetrator of Drug-Drug Interactions
A. Tornio et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Evaluation of Inhibitory Effects of Caffeic acid and Quercetin on Human Liver Cytochrome P450 Activities
Himanshu Rastogi et al.
PHYTOTHERAPY RESEARCH (2014)
Effects of Green Tea Catechins on Cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A Activities in Human Liver and Intestinal Microsomes
Shingen Misaka et al.
DRUG METABOLISM AND PHARMACOKINETICS (2013)
Pharmacokinetic drug interaction between gemfibrozil and sitagliptin in healthy Indian male volunteers
K. P. Arun et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice
Dipak Panigrahy et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Evaluation of CYP2C8 Inhibition In Vitro: Utility of Montelukast as a Selective CYP2C8 Probe Substrate
Brooke M. VandenBrink et al.
DRUG METABOLISM AND DISPOSITION (2011)
Dose-Dependent Interaction between Gemfibrozil and Repaglinide in Humans: Strong Inhibition of CYP2C8 with Subtherapeutic Gemfibrozil Doses
Johanna Honkalammi et al.
DRUG METABOLISM AND DISPOSITION (2011)
Steady-State Pharmacokinetics and Tolerability of Trans-Resveratrol 2000 mg Twice Daily with Food, Quercetin and Alcohol (Ethanol) in Healthy Human Subjects
Charles la Porte et al.
CLINICAL PHARMACOKINETICS (2010)
Effects of myricetin, an antioxidant, on the pharmacokinetics of losartan and its active metabolite, EXP-3174, in rats: possible role of cytochrome P450 3A4, cytochrome P450 2C9 and P-glycoprotein inhibition by myricetin
Dong-Hyun Choi et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
The Structure-Activity Correlation on the Inhibitory Effects of Flavonoids on Cytochrome P450 3A Activity
Masayuki Tsujimoto et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers
Catherine Orrell et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Determinants of cytochrome P4502C8 substrate binding -: Structures of complexes with montelukast, troglitazone, felodipine, and 9-cis-retinoic acid
Guillaume A. Schoch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The development of a cocktail CYP2B6, CYP2C8, and CYP3A5 inhibition assay and a preliminary assessment of utility in a drug discovery setting
Charles J. O'Donnell et al.
DRUG METABOLISM AND DISPOSITION (2007)
Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of CYP2C8: Implications for drug-drug interactions
BW Ogilvie et al.
DRUG METABOLISM AND DISPOSITION (2006)
The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects
M Niemi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Inhibition of human cytochromes P450 by components of Ginkgo biloba
LL von Moltke et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2004)
Validated assays for human cytochrome P450 activities
RL Walsky et al.
DRUG METABOLISM AND DISPOSITION (2004)
Paclitaxel metabolism in rat and human liver microsomes is inhibited by phenolic antioxidants
R Václavíková et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2003)
Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomes
JS Wang et al.
DRUG METABOLISM AND DISPOSITION (2002)
Gemfibrozil greatly increases plasma concentrations of cerivastatin
JT Backman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8:: A new high affinity and turnover enzyme-specific probe substrate
XQ Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Pharmacokinetics and bioavailability of quercetin glycosides in humans
EU Graefe et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Separation and determination of flavonoids and other phenolic compounds in cranberry juice by high-performance liquid chromatography
H Chen et al.
JOURNAL OF CHROMATOGRAPHY A (2001)
Share Paper
